Response and biological subtype of myeloma are independent prognostic factors and combine to define outcome after high-dose therapy

Br J Haematol. 2013 Apr;161(2):291-4. doi: 10.1111/bjh.12218. Epub 2013 Jan 29.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Chromosomes, Human / genetics
  • Disease-Free Survival
  • Female
  • Humans
  • Male
  • Models, Biological*
  • Multiple Myeloma / genetics
  • Multiple Myeloma / mortality*
  • Multiple Myeloma / pathology
  • Multiple Myeloma / therapy*
  • Stem Cell Transplantation
  • Survival Rate
  • Time Factors
  • Translocation, Genetic / genetics
  • Transplantation, Homologous